Synthesis of a novel zinc phthalocyanine with peripherally coordinated Ru(II) complexes; sono-photochemical, photochemical and photophysical studies


JOURNAL OF MOLECULAR STRUCTURE, vol.1261, 2022 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 1261
  • Publication Date: 2022
  • Doi Number: 10.1016/j.molstruc.2022.132886
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Chemical Abstracts Core, INSPEC
  • Keywords: Sono-photochemical, Photochemical, Zinc (II) phthalocyanine, Ruthenium complex, Singlet oxygen, Photosensitizer, PHOTODYNAMIC THERAPY, RUTHENIUM PHTHALOCYANINE, SONODYNAMIC THERAPY, IN-VITRO, CANCER, PHOTOSENSITIZERS, SONOSENSITIZERS, ULTRASOUND, EFFICACY, DESIGN
  • Yıldız Technical University Affiliated: Yes


Sono-photodynamic therapy (SPDT), which is used in the treatment of cancer cells and is advantageous in therapeutic results, has been studied rarely academically as it is a new method. That's why a novel multicomponent system, ZnPc-[Ru(bpy)(2)(phen)](4), as a photosensitizer (Ps) was synthesized by the condensation reaction of the symmetrical zinc phthalocyanine substituted with four 4-(4-formylphenoxy) groups at peripheral positions and ruthenium (II) bis(bipyridine)-phenanthroline complexes including amine group. The compounds were characterized by elemental analysis, FT-IR, H-1 NMR, UV-Vis and MALDI-TOF MS spectral data and analyzed for photophysico-chemical properties. Singlet oxygen quantum yields of the photosensitizer were calculated using photochemical and sono-photochemical methods. When singlet oxygen yields were compared, higher efficiencies were achieved in singlet oxygen production by the sono-photochemical method ( Phi(delta)= 0.72 in DMSO, 0.66 in DMF) compared to the photochemical method (Phi(delta) = 0.45 in DMSO, 0.43 in DMF). This work will lead to the synthesis of new sensitizers with high potential for use in SPDT. (C)& nbsp;2022 Elsevier B.V. All rights reserved.